Table 1.

eGFR before and after 2 yr of weekly treatment with agalsidase alfaa

PatientAge (yr)eGFR (ml/min per 1.73 m2) Pre-EOWDuration of EOW (yr)eGFR (ml/min per 1.73 m2)
Weekly Study EntryWeekly Study 2 yr
143.768.74.028.717.8
249.948.24.524.615.9
348.587.14.062.583.9
624.1142.64.579.060.1
736.882.54.566.179.3
844.2112.52.577.276.5
952.951.14.542.241.9
1045.170.02.063.449.5
1141.159.72.047.438.9
1238.040.32.025.018.8
1431.593.62.574.873.9
Mean41.477.83.453.750.6
SD8.430.41.121.026.0
  • a eGFR, estimated GFR; pre-EOW, baseline before beginning every other week dosing.